Cite
HARVARD Citation
Duma, N. et al. (2019). Sex Differences in Tolerability to Anti‐Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non‐Small Cell Lung Cancer: Are We All Equal?. Oncologist. pp. e1148-e1155. [Online].